Through in-depth exploration, we discovered for the first time the key role of the circ-MTHFD1L/miR-615-3p/RPN6 axis in the process of chemotherapy resistance in pancreatic cancer. This evidence concerns the gene MTHFD1L and familial pancreatic carcinoma.